Rephonic
Artwork for BioSpace

BioSpace

BioSpace
FDA
Eli Lilly
Clinical Trials
Novo Nordisk
Pfizer
Glp-1
Artificial Intelligence
Gene Therapy
Drug Development
China
Merck
Duchenne Muscular Dystrophy
Johnson & Johnson
Sarepta
Women's Health
Biopharma
Job Market
Moderna
Obesity
Astrazeneca

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

PublishesDailyEpisodes254Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BioSpace

Latest Episodes

In this episode of Denatured, you’ll hear from Hans Eriksson, chief medical officer at FundaMental Pharma and Steve Levine, chief patient officer at Compass Pathways. We explore why treatment-resistant depression remains so difficult to address, and ... more

The industry has been abuzz since the weekend when talks of a potential mega-merger between Bristol Myers Squibb and AstraZeneca were reported. Meanwhile, Pfizer, Merck and others release second quarter earnings, with some disclosing pipeline discont... more

In this episode of Denatured presented by Arvinas, Jennifer Smith-Parker speaks to Arvinas President and CEO Randy Teel about the strategic discipline and leadership required to successfully refocus a company on an early-stage pipeline after a lead a... more

The FDA published briefing documents ahead of advisory committee meetings for Capricor Therapeutics’ Duchenne muscular dystrophy therapy and Replimune’s advanced melanoma drug indicating an uphill battle for the biotechs; GSK and AstraZeneca outlined... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Ground Truths
Ground TruthsEric Topol

Recent Guests

Randy Teel
CEO of Arvinas, a biotech company
Arvinas
Episode: Life after the lead asset: Advancing an early-stage pipeline
Linda Marban
CEO of Capricor Therapeutics
Capricor Therapeutics
Episode: Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
Michael Severino
CEO of Sarepta Therapeutics (formerly Hezera CEO)
Sarepta Therapeutics
Episode: Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
Ester Sklarsky
Principal at Sound Bioventures
Sound Bioventures
Episode: Nordic biotech’s next act: From fragmentation to global force
João Ribas
Partner at Novo Holdings Seed Investments
Novo Holdings
Episode: Nordic biotech’s next act: From fragmentation to global force
Lance Alstodt
CEO of BioRestorative Therapies
BioRestorative Therapies
Episode: The future of pain relief: Exploring opioid alternatives
Paul Mieyal
Chief Business Officer for South Rampart Pharma
South Rampart Pharma
Episode: The future of pain relief: Exploring opioid alternatives
Jack Crawford
CEO of Demetra
Demetra
Episode: From sequence to scale: Gene editing’s new era in biologics manufacturing
Magnus Gustafsson
Chief Commercial Officer for NorthX Biologics
NorthX Biologics
Episode: From sequence to scale: Gene editing’s new era in biologics manufacturing

Hosts

Jennifer Smith-Parker
Director of Insights at BioSpace; host on multiple BioSpace programs; senior editor and industry commentator
Jeff Axt
Host and Managing Editor; leads BioSpace weekly and newsletters
Annali Armstrong
Senior Editor; BioSpace; weekly BioPharm Executive and related newsletters
Annaleigh Armstrong
Senior Editor; BioSpace; BioPharm Executive and related newsletters
Heather McKenzie
Senior Editor; host of BioSpace weekly discussions; subject matter expert

Reviews

4.7 out of 5 stars from 33 ratings
  • informative and lively

    Love the podcast. The roundtable discussions are engaging, informative, and lively. The information shared helps keep me current in the biopharma industry.

    Apple Podcasts
    5
    AudraStar
    United States10 months ago
  • Great content, the sound quality needs to improve

    The topics discussed are relevant and interesting. The sound quality needs to improve, especially normalizing the volume of the different speakers and using better microphones to avoid saturation.

    Apple Podcasts
    4
    MarcoMtt
    United States2 years ago
  • Love this podcast

    Love this pod, keep up the good work!

    Apple Podcasts
    5
    Ddxbsbabs
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

- Frequent guests and timely industry coverage keep the content relevant and valuable.
- Sound quality and microphone consistency could improve for a better listening experience.
- The roundtable format is engaging and informative for staying current in biopharma.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Life after the lead asset: Advancing an early-stage pipeline
Q: How does Arvinas balance leveraging platform strength with building new capabilities in neurology and oncology?
Start with what you know well, then add on new areas. Build in areas where you have validated targets and proven biology, then expand into new disease areas by bringing in specialized expertise and designing studies appropriately.
Life after the lead asset: Advancing an early-stage pipeline
Q: When a lead asset is outlicensed or discontinued, what separates companies that reinvent their pipeline from those that stall?
Having strong second-wave programs that are ready to pivot to, plus executing the transition quickly, are critical. The team must align around a clear, external message and ensure internal resources are reorganized to support the new focus on early-stage assets.
Bonus: Q2 2026 Job Market Update
Q: What happened in the biopharma job market during the second quarter of 2026?
The market remains competitive but shows momentum for job seekers: postings increased year over year and quarter over quarter, pharma positions stayed robust across Q2, and biotech R&D postings surged. Overall, it remains an employer's market, but with improving signals and less intense competition than in earlier periods.
Nordic biotech’s next act: From fragmentation to global force
Q: I wanted to ask you about the powerhouse aspect and the role of Novo Nordisk and the foundation in shaping Denmark's biotech pipeline.
The foundation model has been pivotal: it funds early academic research, spins out structures like the BioInnovation Institute, then brings in investors and other stakeholders to scale companies, creating a long-term, synergistic ecosystem.
From sequence to scale: Gene editing’s new era in biologics manufacturing
Q: What are the main methods to introduce the gene of interest into host cells, and how do random integration and targeted editing differ?
Traditionally, random integration uses circular DNA introduced by transfection, landing at unpredictable genomic sites, which is inefficient and unstable; targeted integration uses precise sites (landing pads) or transposase systems to improve stability and expression, though each method has trade-offs in efficiency and timing.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioSpace

What is BioSpace about and what kind of topics does it cover?

A biopharma-focused program that covers science, funding, policy, and industry strategy through roundtable discussions, guest interviews, and market updates. Episodes frequently tackle European and U.S. funding landscapes, manufacturing and commercialization hurdles for cell therapies and fibrosis programs, regulatory shifts, and pharma deal cycles. Noteworthy traits include a strong emphasis on European ecosystem building, practical insights from investors and operators, and ongoing debates about how policy, pricing, and manufacturing scale shape biotech growth. The show is helpful for listeners who want a clear read on what moves the industry, investors, and policymakers are making, and how those moves impact company building and investme... more

Where can I find podcast stats for BioSpace?

Rephonic provides a wide range of podcast stats for BioSpace. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioSpace and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioSpace get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioSpace, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioSpace?

Rephonic provides comprehensive predictive audience data for BioSpace, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioSpace have?

To see how many followers or subscribers BioSpace has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioSpace?

These podcasts share a similar audience with BioSpace:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. Motley Fool Hidden Gems Investing
5. Ground Truths

How many episodes of BioSpace are there?

BioSpace launched 3 years ago and published 254 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioSpace?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioSpace?

Rephonic pulls ratings and reviews for BioSpace from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioSpace?

Rephonic provides full transcripts for episodes of BioSpace. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioSpace?

Recent guests on BioSpace include:

1. Randy Teel
2. Linda Marban
3. Michael Severino
4. Ester Sklarsky
5. João Ribas
6. Lance Alstodt
7. Paul Mieyal
8. Jack Crawford

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days